Validation of quality indicators for evaluating geriatric pharmacotherapy services in primary care: a mixed methods study

Abstract

ObjectiveTo assess measurement properties of 121 face and content validated quality indicators (QIs) for medication safety in geriatric pharmacotherapy in primary care.DesignA mixed methods study: a 6-month observational study in primary care (July–December 2020) and in-depth semistructured online interviews with participants (February–March 2021).SettingSixty community pharmacies in Japan.ParticipantsPatients aged 75 years and older who were regularly taking six or more prescription medicines for ˃4 weeks were eligible. The observational study included 457 patients. The interviews were undertaken with 26 community pharmacists, including pharmacy managers and owners.Primary and secondary outcome measuresFive measurement properties of QIs (applicability, improvement potential, acceptability, implementation issues and sensitivity to change) were evaluated. A web application was developed for data reporting and data visualisation.ResultsThis study showed that 53 QIs met the measurement properties of applicability, improvement potential, acceptability and implementation issues. Of 53 QIs, 17 also had a high sensitivity to change. Interviews identified eight themes (indicator characteristics, web application, policy, patient, time, competence, pharmacy administration and collaboration) in relation to the consequence of implementation of QIs.ConclusionsA set of 121 QIs for geriatric pharmacotherapy was field tested for their five measurement properties. This QI set can be used to identify patients who may benefit from clinician reviews of their medicines. These QIs may be applied at different levels within the healthcare system: patient, pharmacy, regional and national levels. Further mechanisms to automatically collect and report data should be established to facilitate sustainable quality improvement initiatives.

Pharmaceutical Care Network Europe definition of quality indicators for pharmaceutical care: a systematic literature review and international consensus development

“…Hence, QIs are recognised mechanism for evaluating the quality of care if they have been robustly developed and their measurement properties scientifically established. In the field of pharmacy practice, 15 countries have developed QIs: Argentina [ 3 ], Australia [ 4 ], Brazil [ 5 ], Canada [ 6 ], Germany [ 7 ], Japan [ 8 – 10 ], the Netherlands [ 11 , 12 ], Spain [ 13 ], Sweden [ 14 ], Thailand [ 15 ], UK [ 16 ], USA [ 17 ], Ethiopia [ 18 ], Uganda [ 18 ] and Zimbabwe [ 18 ].…”